title: Epigenetic analysis of the human alpha- and beta-globin gene clusters.
abstract: K562 erythroleukemia cells have been widely used as a model for the study of globin gene regulation. A number of agents have been shown to activate or suppress globin gene expression in these cells. However, the molecular effects of these agents on the epigenetic configuration of the alpha- and gamma-globin genes that encode HbF are not known. In this report, we investigated the relationship between globin expression and histone acetylation of the human alpha- and beta-globin clusters in the fetal erythroid environment of K562 cells. Our studies suggest that acetylation of histone H3 may be important in regulating developmental stage-specific expression of the different beta-like globin genes while acetylation of both histones H3 and H4 may be important for the regulation of tissue-specific expression of these genes. In contrast, acetylation of both histones H3 and H4 at the alpha-like globin promoters appears to be important for both developmental stage- and tissue-specific expression. Interestingly, butyrate-induced activation of alpha-globin gene expression in K562 cells is associated with significant increase in histone acetylation levels while TPA-induced inhibition is associated with decreased histone acetylation at its promoters. In contrast, changes in histone acetylation and DNA methylation do not appear to be important in the regulation of gamma-globin gene expression by the same agents. These data suggest that the butyrate-mediated induction of the fetal gamma-globin genes in K562 cells is not a direct result of its histone deacetylase inhibitor activity of butyrate on the chromatin of the gamma-globin promoters, while the induction of the alpha-globin genes could be a result of a direct effect of butyrate on chromatin at its promoters. This is another example of the important differences in the molecular mechanisms of regulation of the genes of the alpha- and beta-like globin clusters.
authors.affiliation: Mount Sinai School of Medicine, Division of Hematology/Medical Oncology, Box 1079, One, Gustave L. Levy Place, New York, NY 10029, USA. hassana.fathallah@mssm.edu
authors.forename: Hassana
authors.initials: H
authors.lastname: Fathallah
authors.forename: Gregory
authors.initials: G
authors.lastname: Portnoy
authors.forename: George F
authors.initials: GF
authors.lastname: Atweh
mesh_terms: D000107:Acetylation; D002087:Butyrates / Q000494:pharmacology; D019175:DNA Methylation; D044127:Epigenesis, Genetic; D015672:Erythroid Precursor Cells / Q000201:enzymology / Q000378:metabolism; D005319:Fetal Hemoglobin / Q000235:genetics / Q000378:metabolism; D018507:Gene Expression Regulation, Developmental; D005914:Globins / Q000235:genetics* / Q000378:metabolism; D006367:HeLa Cells; D006427:Hemin / Q000494:pharmacology; D006655:Histone Deacetylases / Q000235:genetics / Q000378:metabolism*; D006657:Histones / Q000235:genetics / Q000378:metabolism; D006801:Humans; D020014:K562 Cells; D005810:Multigene Family; D011401:Promoter Regions, Genetic
chemical_list: D002087:Butyrates; D006657:Histones; D006427:Hemin; D005914:Globins; D005319:Fetal Hemoglobin; D006655:Histone Deacetylases